AmbAgon Therapeutics logo

AmbAgon Therapeutics

San Francisco, CA

AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.

ambagontx.com

Company Details

Founded

2020

Employees

Between 20 - 100 employees

Raised

$153,000,000

Headquarters Location

San Francisco, CA

Public

No

Acquired

No

CEO

Scott ClarkeScott Clarke

Founders

Christian Ottmann
Christian Ottmann
Michelle Arkin
Michelle Arkin
Lucas Brunsveld
Lucas Brunsveld

Company Collections

These are collections AmbAgon Therapeutics is a part of. Click on the collection name to view similar companies.

AmbAgon Therapeutics' Industries

AmbAgon Therapeutics' Tech Stack

AmbAgon Therapeutics Headquarters Location

953 Indiana Street, San Francisco, CA 94107

Total Amount Raised: $153,000,000

AmbAgon Therapeutics Funding Rounds

  • Series Unknown

    $5,000,000

  • Series Unknown

    $44,999,996

  • Series A

    $85,000,000

    Series A Investors

    Nextech Invest
    AbbVie
    Droia Ventures
    INKEF Capital
    MRL Ventures Fund
    Surveyor Capital
    RA Capital Management
    Mission BioCapital

  • Seed

    $18,000,000

Funding info provided by Diffbot.

AmbAgon Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on AmbAgon Therapeutics.

Recent reviews